PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33722775-6	2021	The 8 kb sequence upstream of Sost gene transcription start site possesses multiple PPARG binding elements (PPREs) with at least two of them binding PPARG with dynamics reflecting its activation with full agonist rosiglitazone and correlating with increased levels of Sost transcript and sclerostin protein expression (Pearson"s r = 0.9910, p = 0.001).	Rosiglitazone	213-226	sclerostin	Mus musculus	30-34	
32845528-0	2021	Sclerostin-Neutralizing Antibody Treatment Rescues Negative Effects of Rosiglitazone on Mouse Bone Parameters.	Rosiglitazone	71-84	sclerostin	Mus musculus	0-10	
32845528-13	2021	These data suggest targeting sclerostin can prevent rosiglitazone-induced bone loss and reduce BM adiposity, in some, but not all BMAT locations.	Rosiglitazone	52-65	sclerostin	Mus musculus	29-39	
29032815-9	2017	Rosiglitazone also induced a greater number of osteoclasts and a greater expression of Sost and Hyou1 at 21 days of lesions.	Rosiglitazone	0-13	sclerostin	Mus musculus	87-91